[Primary and secondary neonatal negative coagulase staphylococcus infections]

Related Experiment Videos

Y Aujard1, C Baumann, J Bloch

  • 1Unité de néonatologie, hôpital Robert-Debré, Paris.

Insights

Coagulase-negative staphylococcal infections in neonates, often linked to catheters in premature infants, require specific antibiotic treatment. This includes vancomycin, aminoglycosides, and rifampicin, dosed by post-conception age, for both infant and mother-to-foetus infections.

Area of Science:

  • Neonatal infections
  • Bacterial pathogenesis
  • Pharmacology

Context:

  • Coagulase-negative staphylococci (CNS) are a common cause of iatrogenic infections in neonates.
  • Premature infants with indwelling catheters are particularly susceptible.
  • Differentiating true infection from sample contamination is crucial.

Purpose:

  • To outline the management of coagulase-negative staphylococcal infections in neonates.
  • To provide guidance on antibiotic selection and dosing for neonatal CNS infections.
  • To address treatment for both infant and mother-to-foetus CNS infections.

Summary:

  • CNS infections in neonates are typically acquired and iatrogenic, often associated with indwelling catheters in premature infants.
  • Clinical and laboratory criteria aid in distinguishing true infections from contaminated samples.
  • Treatment involves vancomycin, an aminoglycoside, and initially rifampicin, with dosages adjusted for post-conception age.

Impact:

  • Informs clinical practice for managing neonatal staphylococcal infections.
  • Highlights the importance of appropriate antibiotic therapy and dosing in vulnerable neonates.
  • Provides a treatment strategy for CNS infections, including vertical transmission.

Related Concept Videos